Encouraging early trial results of ofatumumab for relapsing remitting MS
From the MS Trust:
Results of a small phase II trial of the drug ofatumumab have been released. The trial primarily tested the safety of the drug, but also looked at the effect on brain lesions as measured by MRI. For more click here.